Cargando…

Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies

Vaccination and administration of monoclonal antibody cocktails are effective tools to control the progression of infectious diseases and to terminate pandemics such as COVID-19. However, the emergence of SARS-CoV-2 mutants with enhanced transmissibility and altered antigenicity requires broad-spect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Hongyu, Yuan, Xin-Yong, Cabral, Teresa, Manguiat, Kathy, Robinson, Alyssia, Wood, Heidi, Grant, Chris, McQueen, Peter, Westmacott, Garrett, Beniac, Daniel R., Lin, Lisa, Carpenter, Michael, Kobasa, Darwyn, Gräfenhan, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572761/ https://www.ncbi.nlm.nih.gov/pubmed/34762975 http://dx.doi.org/10.1016/j.antiviral.2021.105206

Ejemplares similares

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
por: Merluza, John, et al.
Publicado: (2023)

Non-Productive Infection of Glial Cells with SARS-CoV-2 in Hamster Organotypic Cerebellar Slice Cultures
por: Lamoureux, Lise, et al.
Publicado: (2022)

Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
por: Rahim, Md Niaz, et al.
Publicado: (2019)

Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS‐CoV‐2
por: Mendoza, Emelissa J., et al.
Publicado: (2020)

A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea
por: Willman, Marnie, et al.
Publicado: (2019)

Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease
por: Deschambault, Yvon, et al.
Publicado: (2022)

Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody
por: Zhu, Wenjun, et al.
Publicado: (2023)

Comprehending a Killer: The Akt/mTOR Signaling Pathways Are Temporally High-Jacked by the Highly Pathogenic 1918 Influenza Virus
por: Ranadheera, Charlene, et al.
Publicado: (2018)

Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

MS-H: A Novel Proteomic Approach to Isolate and Type the E. coli H Antigen Using Membrane Filtration and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
por: Cheng, Keding, et al.
Publicado: (2013)

Correction for Valcourt et al., “Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays”
por: Valcourt, Emelissa J., et al.
Publicado: (2022)

Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020)
por: Drews, Steven, et al.
Publicado: (2022)

Comparative Analysis of Outer Membrane Vesicle Isolation Methods With an Escherichia coli tolA Mutant Reveals a Hypervesiculating Phenotype With Outer-Inner Membrane Vesicle Content
por: Reimer, Shelby L., et al.
Publicado: (2021)

The interaction between the Nipah virus nucleocapsid protein and phosphoprotein regulates virus replication
por: Ranadheera, Charlene, et al.
Publicado: (2018)

Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice
por: Hagan, Mable, et al.
Publicado: (2016)

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
por: Olukitibi, Titus A., et al.
Publicado: (2023)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters
por: Griffin, Bryan D., et al.
Publicado: (2021)

Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays
por: Yang, Ming, et al.
Publicado: (2022)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation
por: Dust, Kerry, et al.
Publicado: (2022)

Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus
por: Summerfield, Artur, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1
por: Nfon, Charles, et al.
Publicado: (2012)

Aptamer Profiling of A549 Cells Infected with Low-Pathogenicity and High-Pathogenicity Influenza Viruses
por: Coombs, Kevin M., et al.
Publicado: (2019)

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV
por: Phelps, Amanda L., et al.
Publicado: (2021)

Momentum: how to build it, keep it or get it back
por: McQueen, Michael
Publicado: (2016)

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
por: Schieffelin, John S, et al.
Publicado: (2010)

The Disinfection Characteristics of Ebola Virus Outbreak Variants
por: Cook, Bradley W. M., et al.
Publicado: (2016)

Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination
por: Nikiforuk, Aidan M., et al.
Publicado: (2016)

Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry
por: Ao, Zhujun, et al.
Publicado: (2021)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody
por: Hu, Wei-Gang, et al.
Publicado: (2012)

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
por: Ahmadi, Shirin, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_honm7lmlp4qo64k06mqn75i83m